Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

102.33 -0.87 (-0.84%)
Official Closing Price Updated: 5:00 PM EDT, Jul 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,017,848
Open 103.36
Bid (Size) 102.30 (1)
Ask (Size) 103.43 (1)
Prev. Close 103.20
Today's Range 102.18 - 103.66
52wk Range 89.67 - 121.64
Shares Outstanding 1,750,942,289
Dividend Yield 1.99%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The 3 Best Healthcare Stocks to Buy in July 2024
Consistent breakthroughs, improved products and relatively consistent growth make these the best healthcare stocks to buy. 
Via InvestorPlace
AbbVie Stock: A Perfect Dip for Investors to Buy
ABBV stock is down over 3% to start the second half of the year; the stock may be overvalued in the short term but still offers value for long-term investors 
Via MarketBeat
Topics ETFs

Performance

YTD
-6.85%
-6.85%
1 Month
-0.52%
-0.52%
3 Month
-8.04%
-8.04%
6 Month
-6.57%
-6.57%
1 Year
-4.69%
-4.69%

More News

Read More
7 Dividend Aristocrats That Will Have Investors in High-Yield Heaven
Via InvestorPlace
Topics Stocks
Exposures US Equities
7 Analysts Have This To Say About Abbott Laboratories
Via Benzinga
3 MedTech Stocks to Buy for Healthy Gains
Via InvestorPlace
Market Whales and Their Recent Bets on ABT Options
Via Benzinga
Abbott Laboratories's Options: A Look at What the Big Money is Thinking
Via Benzinga
Stocks Going Ex Dividend In July 2024
Via Talk Markets
Hot Summer Dividends: 3 Sizzling Stocks to Buy for Reliable Income
Via InvestorPlace
Top Analyst Reports For Abbott, BP & Gilead
Via Talk Markets
10 Stocks to Build a Dividend Portfolio That Will Pay You $1,000s per Year
Via The Motley Fool
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
Via The Motley Fool
2 Healthcare Stocks to Buy Hand Over Fist in June
Via The Motley Fool
2 Magnificent Dividend Growth Stocks to Buy Now
Via The Motley Fool
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
Via Investor's Business Daily
Exposures Product Safety
Class Action Against Abbott's Glucerna Products Proceeds in Federal Court
Via Benzinga
The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Berkshire Hathaway, Chipotle, More NYSE Stocks Hit With Trading Halts Triggered By Technical Issues
Via Benzinga
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
Via The Motley Fool
The 3 Best MedTech Stocks to Buy Now: May 2024
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for May 2024
Via InvestorPlace
Reliable Rewards: 7 Dividend Stocks to Count On in Any Market
Via InvestorPlace
Blue-Chip Bonanza: 3 Stocks to Ride the Market’s Coattails to Riches
Via InvestorPlace
8 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.